Results 31 to 40 of about 6,304 (206)

Frontotemporal Brain Sagging Syndrome as a Treatable Cause Mimicking Frontotemporal Dementia: A Case Report

open access: yesCase Reports in Neurology, 2022
Frontotemporal brain sagging syndrome (FBSS) is a progressive disorder characterized by symptoms similar to the behavioral variant of frontotemporal dementia (FTD), with a sagging appearance of the brain on imaging similar to that observed in spontaneous
Atsuhiko Sugiyama   +5 more
doaj   +1 more source

Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia

open access: yesNature and Science of Sleep, 2022
Michael J Thorpy,1 Isabelle Arnulf,2 Nancy Foldvary-Schaefer,3 Anne Marie Morse,4 Karel Šonka,5 Patricia Chandler,6 Luke Hickey,7 Abby Chen,6 Jed Black,6,8 Amanda Sterkel,6 Dan Chen,9 Richard K Bogan,10 Yves Dauvilliers11,12 1Albert Einstein ...
Thorpy MJ   +12 more
doaj  

Compromised Dynamic Cerebral Autoregulation in Patients With Central Disorders of Hypersomnolence

open access: yesFrontiers in Neurology, 2021
Objective: We aimed to investigate the dynamic cerebral autoregulation (dCA) in patients with central disorders of hypersomnolence during wakefulness.Methods: Thirty-six patients with central disorders of hypersomnolence were divided into three groups ...
Fang Deng   +7 more
doaj   +1 more source

Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts [PDF]

open access: yes, 2020
Summary The aim of this European initiative is to facilitate a structured discussion to improve the next edition of the International Classification of Sleep Disorders (ICSD), particularly the chapter on central disorders of hypersomnolence. The ultimate
Reading P. J.   +49 more
core   +1 more source

The Swiss Primary Hypersomnolence and Narcolepsy Cohort study (SPHYNCS): Study protocol for a prospective, multicentre cohort observational study. [PDF]

open access: yes, 2021
Narcolepsy type 1 (NT1) is a disorder with well-established markers and a suspected autoimmune aetiology. Conversely, the narcoleptic borderland (NBL) disorders, including narcolepsy type 2, idiopathic hypersomnia, insufficient sleep syndrome and ...
Arto Nirkko   +61 more
core   +1 more source

Kleine-Levin syndrome and idiopathic hypersomnia: Spectrum disorders

open access: yesIndian Journal of Psychological Medicine, 2011
Kleine-Levin syndrome (KLS) and idiopathic hypersomnia (IH) are primary sleep disorders of unknown etiologies, which often run a chronic course. The common core symptoms of these syndromes are hypersomnolence and sleep drunkenness, with periodic ...
Ravi Gupta   +2 more
doaj   +1 more source

Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)

open access: yesNature and Science of Sleep, 2023
Joanne Stevens,1 Logan D Schneider,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden1 1Global Medical Affairs, Jazz Pharmaceuticals, Philadelphia, PA, USA; 2Stanford University Sleep Medicine Center, Stanford University ...
Stevens J   +6 more
doaj  

Applicability of the Sustained Attention to Response Task (SART) in hypersomnolence: Experience and results from a tertiary referral center

open access: yes, 2023
Objective/backgroundEvaluation of hypersomnolence disorders ideally includes an assessment of vigilance using the short Sustained Attention to Response Task (SART).
Mojca Kristina Maria van Schie   +11 more
core   +1 more source

The diagnostic value of sleep and vigilance tests in central disorders of hypersomnolence. [PDF]

open access: yes, 2022
STUDY OBJECTIVES This retrospective cross-sectional observational study explored the diagnostic value of selected sleep and vigilance tests (SVT) beyond the multiple sleep latency test to differentiate between various central disorders of ...
Mathis, Johannes   +5 more
core   +1 more source

Sertraline as an adjunctive treatment for insomnia comorbid with other mental health disorders

open access: yesJournal of Affective Disorders Reports, 2022
The selective serotonin reuptake inhibitor (SSRI), sertraline, enhances serotonergic transmission and is used in the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety ...
K. Gandotra   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy